Paragon 28 Inc. logo

Paragon 28 Inc. (FNA)

Delisted
17 Apr 2025
NYSE NYSE
$
13. 09
0
0%
$
835.53M Market Cap
- P/E Ratio
- Div Yield
19.38M Volume
-0.44 Eps
$ 13.09
Previous Close
Day Range
13.06 13.11
Year Range
4.65 13.13
Want to track FNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

FNA Chart

Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength?

Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength?

Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks | 1 year ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FNA.

Accesswire | 1 year ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / January 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FNA.

Accesswire | 1 year ago

Paragon 28 Inc. (FNA) FAQ

What does "Delisted" mean?

Paragon 28 Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

No stock splits were recorded prior to delisting.

What was the last known trading price?

The stock last traded at $13.09 on Apr 17, 2025 before being delisted.

Paragon 28 Inc. Profile

- Industry
- Sector
Mr. Albert DaCosta CEO
NYSE Exchange
69913P105 CUSIP
US Country
574 Employees
- Last Dividend
- Last Split
15 Oct 2021 IPO Date

Overview

Paragon 28, Inc., founded in 2010 and based in Englewood, Colorado, is a pioneering company in the development, distribution, and sale of innovative foot and ankle surgical systems both in the United States and internationally. The company has established itself as a leader in the industry by focusing on the creation of specific solutions designed to improve surgical outcomes for patients suffering from foot and ankle conditions. Through its extensive range of products, Paragon 28, Inc. caters to hospitals and ambulatory surgery centers, delivering its services via a comprehensive network of sales representatives and stocking distributors.

Products and Services

Paragon 28, Inc. offers a wide array of products and services designed to meet the diverse needs of foot and ankle surgery, including:

  • Plating Systems: The company provides various plating systems such as the Gorilla Plating System which includes lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems. Additionally, they offer specialized systems like the Baby Gorilla Plate-Specific Screws, Navicular Fracture Plates, and 5th Metatarsal Hook Plates, alongside the Silverback Plating System.
  • Precision Guide Technology: This technology is utilized in procedures such as fusion for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. This suite of tools and guides aims to increase surgical precision and outcomes.
  • Beaming Screw Systems: The Monster, Mini Monster, and Joust beaming screw systems are designed for bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation, offering robust options for various surgical needs.
  • APEX 3D Total Ankle Replacement System: This state-of-the-art system provides a solution for total ankle replacement, aiming to restore mobility and reduce pain for patients with ankle joint issues.
  • Total Talus Spacers: Specifically designed to replace the talus bone in the ankle, these spacers are used in severe cases where the talus and connecting bone in the leg and foot need replacement.
  • Forefoot/Hallux Valgus Correction Systems: Including the Phantom Intramedullary Nail System for the treatment of severe hallux valgus, these systems offer targeted solutions for forefoot deformities.
  • Orthobiologics: Paragon 28, Inc. provides a comprehensive range of orthobiologic products including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. The PRESERVE Bone Graft System, designed for homologous application, is also part of their offering.
  • Additional Products: The company's portfolio also includes soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization systems, and curved instruments, further supporting a wide range of surgical needs and procedures.

Contact Information

Address: 14445 Grasslands Drive, Englewood, CO, United States, 80112
Phone: 855 786 2828